Ryan Haumschild, PharmD, MS, MBA: Dr Dent, we've talked a lot about alpelisib and the amazing benefits it offers. What are some other treatments that can be used in this trajectory? What are other … [Read more...] about Emerging Treatment Routes for the Treatment of HR+/HER2 Breast Cancer
fulvestrant
Treatment options in patients with PIK3CA mutation
Ryan Haumschild, PharmD, MS, MBA: Dr. Dent, as more and more data comes out, it's an exciting time. But we know that data from the BYLieve study was recently presented in the San Antonio [Breast … [Read more...] about Treatment options in patients with PIK3CA mutation
Using multidisciplinary and patient-centered care to manage drug toxicity
Ryan Haumschild, PharmD, MS, MBA: Speaking of the experts, when it comes to toxicity management, I can't look any further than my fellow pharmacist here. dr. Moore, we know there's a toxicity … [Read more...] about Using multidisciplinary and patient-centered care to manage drug toxicity
